This bill requires the Securities and Exchange Commission (SEC) to revise two specific regulations within 180 days of enactment. It would change the definition of "qualifying investments" for venture capital funds to include equity securities from qualifying companies (purchased directly or in secondary markets) and allow investments in other venture capital funds to count toward qualification. These revisions would directly affect venture capital funds seeking to maintain their regulatory status by altering the types of investments they can hold. The changes aim to adjust how venture capital funds structure their portfolios under current SEC rules.
HR 4431, the Improving Capital Allocation for Newcomers Act of 2025, changes rules for certain venture capital funds under the Investment Company Act of 1940. It raises the maximum number of investors allowed from 250 to 2,000 and increases the asset threshold from $10 million to $150 million for funds seeking an exemption. This directly affects venture capital funds that want to operate under the 3(c)(1) exemption, allowing them to pool capital from more investors and manage larger funds without full SEC registration. The bill makes these specific numerical adjustments to the existing exemption rules.
This bill reduces the required aggregate market value of voting and non-voting common equity shares for an issuer of securities to qualify as a well-known seasoned issuer. A well-known seasoned issuer is allowed to make expedited public offerings of securities through automatic shelf registrations.
The No New Burma Funds Act (HR 4423) extends the existing pause on World Bank payments and new financial commitments to Burma's government. This pause, initiated after the 2021 military coup that overthrew Burma's democratically elected government, prevents the Burmese government from accessing new international funding. The bill directs the U.S. Treasury Secretary to instruct the U.S. representative at the World Bank to maintain this pause unless they determine it is not in the public interest. The bill directly affects Burma's government by restricting its access to World Bank financial support.
HR 4313, the Hospital Inpatient Services Modernization Act, extends Medicare's waiver allowing acute hospital care at home until 2030 (previously expiring in 2025). It requires the Secretary of Health and Human Services to conduct a detailed study by September 2028 comparing home-based hospital care to traditional inpatient care. The study must analyze quality metrics (like readmission rates and patient outcomes), costs, staffing patterns, and patient demographics - including racial, ethnic, and socioeconomic data - across participating and non-participating hospitals. This bill directly affects Medicare beneficiaries receiving home-based care and hospitals operating under the waiver program.
HR 3716, the Systemic Risk Authority Transparency Act, requires greater transparency around bank failures involving institutions covered by FDIC insurance. It mandates two key reports: first, the GAO must review and report to Congress within 60 days (and again 180 days) after a bank failure determination, examining factors like mismanagement, regulatory gaps, and the bank’s compensation practices. Second, the relevant federal banking agency must submit a detailed report to Congress within 90 days (and again 210 days) after such a determination, including examination records, supervisory communications, and causes of the failure, while protecting sensitive information. The bill aims to improve congressional oversight of bank failures and systemic risks without altering regulatory enforcement authority.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
The HUD Transparency Act of 2025 requires the Inspector General of the Department of Housing and Urban Development (HUD) to testify annually before specific congressional committees. Each October 1, the IG must report on six key areas: fraud prevention efforts, audit capabilities, program improvements, efficiency recommendations, resource sufficiency for HUD’s mission, and ongoing oversight activities. This bill directly affects HUD’s Inspector General and Congress, mandating structured, annual accountability reporting. It creates a concrete mechanism for Congress to monitor HUD’s oversight effectiveness without altering HUD’s programs or funding. The law focuses on transparency in existing oversight processes, not new policy changes.
This bill denies immigration benefits to individuals who participated in, supported, or facilitated Hamas attacks against Israel starting October 7, 2023. It amends immigration law to make such individuals inadmissible (barred from entering the U.S.) and ineligible for any immigration relief, including asylum or other protections. The law requires annual reports from the Homeland Security Secretary tracking how many people are denied entry or removed under these provisions. It directly affects non-U.S. nationals involved in Hamas-related violence against Israel since the October 7, 2023, attacks.
HCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
Courthouse Affordability and Space Efficiency (CASE) Act of 2025 This bill provides statutory authority for the General Services Administration (GSA) courtroom sharing policy and limits construction of new courthouses. Under the bill, GSA must ensure courtroom sharing by magistrate, bankruptcy, and senior district judges. Specifically in courthouses with 10 or more active district judges, GSA must provide two courtrooms per 3 active district judges (except such courthouses may contain not less than 9 courtrooms for active district judges); in courthouses with 3 or more bankruptcy judges, GSA must provide one courtroom per 2 bankruptcy judges; in courthouses with 3 or more senior district judges, GSA must provide one courtroom per 2 senior district judges; and in courthouses with 3 or more magistrate judges, GSA must provide one courtroom per 2 magistrate judges. GSA is prohibited from constructing a new courthouse that does not comply with the courtroom sharing requirements. Additionally, if a new courthouse will add capacity in the GSA inventory, existing space in the same courthouse complex must be fully utilized or relinquished from such inventory. GSA must update the U.S. Courts Design Guide to reflect these requirements within 180 days after the bill's enactment. (The Design Guide sets forth the federal judiciary’s requirements for the design, construction, and renovation of court facilities and is intended for use by individuals involved in federal court construction projects.)
HR 3109, the REFINER Act, requires the U.S. Department of Energy to direct the National Petroleum Council to submit a report within 90 days of enactment. The report must examine U.S. petrochemical refineries' role in energy security, analyze their current capacity and expansion opportunities, assess risks to these facilities, and evaluate federal or state policies that may have reduced refinery capacity. It also mandates recommendations for increasing refinery capacity and requires the report to be made publicly available. This bill directly affects refineries, federal agencies, and Congress by mandating a comprehensive study on the sector's status and future needs.
